Tempest Minerals Limited (ASX:TEM) Announces Inaugural Resource Estimate
Tempest Minerals (ASX:TEM) announces a 63.5 Mt @ 30.6% Fe inaugural resource estimate for the Remorse Deposit, paving the way for future development.
Tempest Minerals (ASX:TEM) announces a 63.5 Mt @ 30.6% Fe inaugural resource estimate for the Remorse Deposit, paving the way for future development.
LTR Pharma (ASX:LTP) collaborates with SDS to develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders.
Geopacific Resources (ASX:GPR) reveals 14 new porphyry Cu-Au targets at Woodlark Gold Project, boosting exploration prospects.
Brightstar Resources (ASX:BTR) announces significant gold drilling results, advancing exploration and operational activities.
Algorae Pharmaceuticals (ASX:1AI) partners with Peter MacCallum Cancer Centre to validate AI-driven drug synergies in oncology.
Pro Medicus Limited (ASX:PME) signs a A$20M, 5-year contract with University of Iowa Health Care for its cloud-based Visage 7 platform.
Helloworld Travel (ASX:HLO) revises FY25 UEBITDA guidance due to market volatility, while reporting strong operational performance.
Nyrada Inc. (ASX:NYR) reports significant cardioprotective findings for NYR-BI03 in preclinical studies, demonstrating potential for treating heart attack-related conditions.
Sunshine Metals (ASX:SHN) reports a 64.50g/t gold discovery at Mt Pleasant and updates progress on Liontown oxide gold drilling, outlining 2025 exploration plans.
Rimfire Pacific Mining (ASX:RIM) reports significant scandium intercepts from Currajong drilling, emphasizing strategic supply potential amid Chinese export restrictions.